Mong‐Liang Lu

4.3k total citations
128 papers, 2.9k citations indexed

About

Mong‐Liang Lu is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Mong‐Liang Lu has authored 128 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Psychiatry and Mental health, 21 papers in Pharmacology and 21 papers in Clinical Psychology. Recurrent topics in Mong‐Liang Lu's work include Schizophrenia research and treatment (33 papers), Bipolar Disorder and Treatment (30 papers) and Treatment of Major Depression (18 papers). Mong‐Liang Lu is often cited by papers focused on Schizophrenia research and treatment (33 papers), Bipolar Disorder and Treatment (30 papers) and Treatment of Major Depression (18 papers). Mong‐Liang Lu collaborates with scholars based in Taiwan, United Kingdom and United States. Mong‐Liang Lu's co-authors include Chun-Hsin Chen, Winston W. Shen, Chih-Chiang Chiu, Ming‐Chyi Huang, Po‐Hsiu Kuo, Vincent Chin‐Hung Chen, Kah Kheng Goh, Shih‐Ku Lin, Tsu‐Nai Wang and Wen‐Ho Chang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Mong‐Liang Lu

128 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mong‐Liang Lu Taiwan	30	1.2k	549	547	532	458	128	2.9k
Ric M. Procyshyn Canada	33	1.6k 1.4×	439 0.8×	557 1.0×	396 0.7×	230 0.5×	143	3.2k
Margaret Hahn Canada	32	1.2k 1.1×	652 1.2×	860 1.6×	322 0.6×	462 1.0×	148	2.9k
Vicki L. Ellingrod United States	30	1.2k 1.0×	695 1.3×	556 1.0×	245 0.5×	363 0.8×	131	3.1k
Ming‐Chyi Huang Taiwan	27	618 0.5×	411 0.7×	347 0.6×	348 0.7×	430 0.9×	166	2.5k
Winston W. Shen Taiwan	30	1.2k 1.1×	338 0.6×	369 0.7×	478 0.9×	368 0.8×	110	3.1k
John Lally United Kingdom	27	2.0k 1.8×	236 0.4×	378 0.7×	607 1.1×	451 1.0×	99	3.4k
Mehdi Farokhnia United States	33	583 0.5×	508 0.9×	579 1.1×	245 0.5×	523 1.1×	95	2.9k
Urban Ösby Sweden	33	2.9k 2.5×	423 0.8×	491 0.9×	1.1k 2.0×	474 1.0×	68	5.0k
Ping‐Tao Tseng Taiwan	31	1.0k 0.9×	346 0.6×	806 1.5×	407 0.8×	304 0.7×	160	3.8k
Shih‐Ku Lin Taiwan	31	1.3k 1.2×	413 0.8×	256 0.5×	420 0.8×	281 0.6×	126	3.0k

Countries citing papers authored by Mong‐Liang Lu

Since Specialization

Citations

This map shows the geographic impact of Mong‐Liang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mong‐Liang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mong‐Liang Lu more than expected).

Fields of papers citing papers by Mong‐Liang Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mong‐Liang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mong‐Liang Lu. The network helps show where Mong‐Liang Lu may publish in the future.

Co-authorship network of co-authors of Mong‐Liang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Mong‐Liang Lu. A scholar is included among the top collaborators of Mong‐Liang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mong‐Liang Lu. Mong‐Liang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gau, Susan Shur‐Fen, Chun‐Hsin Chen, Hsin‐Chien Lee, et al.. (2024). Determining cut-off values and predictors for the Snaith–Hamilton Pleasure Scale: comparison between clinical and school settings. BJPsych Open. 10(3). e106–e106. 3 indexed citations

Chen, Hsi‐Chung, Chun‐Hsin Chen, I‐Ming Chen, et al.. (2023). Exploring the human gut microbiota targets in relation to the use of contemporary antidepressants. Journal of Affective Disorders. 344. 473–484. 12 indexed citations

Su, Mei‐Hsin, Shih‐Cheng Liao, Hsi‐Chung Chen, et al.. (2022). The association of personality polygenic risk score, psychosocial protective factors and suicide attempt in mood disorder. Journal of Psychiatric Research. 156. 422–428. 6 indexed citations

Wu, Tzu‐Hua, Chieh‐Hsin Lin, Kah Kheng Goh, et al.. (2021). The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment. Frontiers in Pharmacology. 12. 718800–718800. 7 indexed citations

Chen, Chun‐Hao, Mong‐Liang Lu, Chun‐Hsin Chen, et al.. (2021). Differential Co-Occurring Patterns Between Depressive Symptomatology and Sleep-Wake-Related Disturbances in Mood Disorders. Nature and Science of Sleep. Volume 13. 503–514. 4 indexed citations

Chen, Pao‐Huan, Hsing‐Cheng Liu, Mong‐Liang Lu, et al.. (2019). Homocysteine, rather than age of onset, is a better predictor for cognitive function in older adults with bipolar disorder. International Journal of Geriatric Psychiatry. 34(10). 1473–1480. 4 indexed citations

Yang, Yao‐Hsu, et al.. (2019). Antidepressants Reduced Risk of Mortality in Patients With Diabetes Mellitus: A Population-Based Cohort Study in Taiwan. The Journal of Clinical Endocrinology & Metabolism. 104(10). 4619–4625. 13 indexed citations

Wu, Tzu‐Hua, Chih-Chiang Chiu, Po‐Yu Chen, et al.. (2019). Obsessive-compulsive symptoms in patients with schizophrenia: Relationships with olanzapine pharmacological parameters, psychopathology, and quality of life. Psychiatry Research. 276. 1–5. 7 indexed citations

Chen, Vincent Chin‐Hung, et al.. (2018). Leptin/Adiponectin ratio as a potential biomarker for metabolic syndrome in patients with schizophrenia. Psychoneuroendocrinology. 92. 34–40. 45 indexed citations

10.

Chen, Vincent Chin‐Hung, Yao‐Hsu Yang, Mong‐Liang Lu, et al.. (2018). Association between enterovirus infection and speech and language impairments: A nationwide population-based study. Research in Developmental Disabilities. 77. 76–86. 6 indexed citations

11.

Chen, Vincent Chin‐Hung, Wei‐Che Chiu, Peter Ho, et al.. (2017). Prostate cancer and antidepressants: A nationwide population-based nested case-control study. Journal of Affective Disorders. 227. 834–839. 3 indexed citations

12.

Lu, Mong‐Liang, Vincent Chin‐Hung Chen, Meng‐Jer Hsieh, et al.. (2017). Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan. PLoS ONE. 12(3). e0173063–e0173063. 24 indexed citations

13.

Chen, Vincent Chin‐Hung, Yin‐To Liao, Te-Jen Lai, et al.. (2015). Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study. Schizophrenia Research. 169(1-3). 406–411. 11 indexed citations

14.

Lu, Mong‐Liang, et al.. (2014). Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 58. 47–50. 41 indexed citations

15.

Chen, Chun-Hsin, Ming‐Chyi Huang, Chung‐Feng Kao, et al.. (2013). Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight. The Journal of Clinical Psychiatry. 74(5). e424–e430. 60 indexed citations

16.

Chiu, Chih-Chiang, et al.. (2012). The Relationship Between Serum Uric Acid Concentration and Metabolic Syndrome in Patients With Schizophrenia or Schizoaffective Disorder. Journal of Clinical Psychopharmacology. 32(5). 585–592. 12 indexed citations

17.

Chen, Po‐Yu, Ming‐Chyi Huang, Chih-Chiang Chiu, et al.. (2011). Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(8). 1927–1932. 13 indexed citations

18.

Kuo, Po‐Hsiu, Chung‐Feng Kao, Po‐Yu Chen, et al.. (2011). Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients. Journal of Clinical Psychopharmacology. 31(6). 705–711. 24 indexed citations

19.

Chen, Chun-Hsin, et al.. (2011). A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(4). 965–969. 12 indexed citations

20.

Tsai, Ming‐Hsien, Keh-Ming Lin, Mei‐Chun Hsiao, et al.. (2010). Genetic Polymorphisms of Cytochrome P450 Enzymes Influence Metabolism of the Antidepressant Escitalopram and Treatment Response. Pharmacogenomics. 11(4). 537–546. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact